HIV and AIDS Trial, Recruiting NCT05789901 Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre Condition: HIV and AIDS
Back to Hiv Aids

HIV and AIDS Trial, Recruiting

NCT05789901
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are 14 years of age or older
  • People who are fluent in English and/or French
  • People who are able to understand what taking part in the study involves and can give their consent to participate throughout the study
  • People who have access to a smartphone, tablet, or computer at home or at work
  • People who have access to an internet connection at home or a data plan on their device
  • For some parts of the trial only: people who are willing to use a chatbot on Facebook Messenger
  • For some parts of the trial only: people who are willing to use or create a personal Facebook account
  • For some parts of the trial only: people who are willing to agree to Facebook's privacy and data security policies

Who may not be able to join:

  • People who do not meet the inclusion criteria listed above
  • People who the trial investigator considers unsuitable for a study involving a chatbot for any reason, such as having a cognitive condition that could affect participation (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Bertrand Lebouché, MD, McGill University Health Centre/Research Institute of the McGill University Health Centre

Phone: 514-843-2090

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
McGill University Health Centre/Research Institute of the McGill University Health Centre
Registry
ClinicalTrials.gov
Start date
1 March 2024
Est. completion
31 December 2033

Where this trial is recruiting

🇨🇦 Canada

Primary endpoints

Usability Metric for User eXperience (UMUX-Lite); Acceptability E-Scale (AES); Change in Acceptability E-Scale (AES) over 12 months; Change in Intervention Appropriateness Measure (IAM) over 12 months; Change in Compatibility Subscale over 12 months

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov